The clinical value of neuron-specific enolase as a marker in small cell lung cancer, neuroblastoma, melanoma and seminoma has been reviewed The role of serum and cerebrospinal NSE in benign and malignant disease of the central nervous sytem is discussed.
MooreB.W., McGregorT.Chromatographic and electrophoretic fractionation of soluble proteins of brain and liver.J Biol Chem1965; 240: 1647–53.
2.
PrinzR.A., MarangosP.J.Use of neuron specific enolase as a serum marker for neuroendocrine neoplasms.Surgery1982; 97: 887–9.
3.
CarneyD.N., MarangosP.J., IhdeD.C.Serum neuron specific enolase: a marker for disease extent and response to therapy in small cell lung cancer.Lancet1982; 13: 583–5.
4.
BorkE., HansensM., UrdalP.Early detection of response in small cell bronchogenic carcinoma by changes in serum creatine kinase, neuron specific enolase, calcitonin, ACTH, serotonin and gastrin releasing peptide.Eur J Cancer Clin Oncol1988; 24: 1033–8.
5.
RapellinoM., PecchioF., RuffiniE., CellerinoE.Pathophysiology and clinics of neuron specific enolase (NSE). In: BallestaA.M., TorreG.C., BombardieriE., GionM., MolinaR., eds. Up dating on tumor markers in tissues and biological fluids.Torino: Edizioni Minerva Medica, 1993, 283–97.
6.
SouhamiR.L., BradburyI., GeddesD.M., SpiroS.G., HarperP.G., TobiasJ.S.Prognostic significance of laboratory parameters measured at diagnosis in small cell carcinoma of the lung.Cancer Res1985; 45: 2878–82.
7.
OsterlindK., AndersenP.K.Prognostic factors in small cell lung cancer: Multivariate model based on 778 patients treated with chemotherapy with or without radiotherapy.Cancer Res1986; 46: 4189–94.
8.
JorgensenL.G.M., OsterlindK., HansenH.H., CooperE.H.The prognostic influence of serum neuron specific enolase in small cell lung cancer.Br J Cancer1988; 58: 805–7.
9.
HardingM., McAllisterJ., HulksG., VernonD., MonieR., PaulJ., KayeS.B.Neurone specific enolase in small cell lung cancer: a tumour marker of prognostic significance?Br J Cancer1990; 61: 605–7.
10.
JorgensenL.G.M., OsterlindK., HansenH.H., CooperE.H.Serum neuron specific enolase as a determinant of response duration in small cell lung cancer.Br J Cancer1992; 66: 594–8.
11.
SzturmowiczM., RoginskaE., RoskzkowskiK., ZwiekS., FilipeckiS., Rowinska-ZakrzewskaE.Prognostic value of neuron specific enolase in small cell lung cancer patients.Lung Cancer1993; 8: 259–64.
12.
JohnsonP.W.M., JoelS.P., LoveS.Tumour markers for prediction of survival and monitoring remission in small cell lung cancer.Br J Cancer1993; 67: 760–7.
13.
SplinterT.A.W., CarneyD.N., TeelingM., PeakeM.D., KhoG.S., OosteromR., CooperE.H.Levels of neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer.J Cancer Res Clin Oncol1988; 114: 641–3.
NouE., SteinholtzL., BerghJ., NilssonK., PåhlmanS.Neuron-specific enolase, a follow up marker in small cell bronchial carcinoma: a prospective study in an unselected series.Cancer1990; 65: 1380–5.
16.
SplinterT.A.W., CarneyD.N., TeelingM.Neuron specific enolase can be used as the sole guide to treat small cell lung cancer patients in common clinical practice.J Cancer Res Clin Oncol1989; 115: 400–1.
17.
ZandwijkN., JasemE., BonferJ.M., van TinterenH.Value of neuron specific enolase in early detection of relapse in small cell carcinoma.Eur J Cancer1990; 26: 373–6.
18.
RuibalA., EncaboG., GenollaJ.La enolasa especifica neuronal serica en pacientes de pathalogica no tumorales.Rev Esp Oncologia1985; 32: 183–6.
BergmanB., BrezickaF.T., EngstromC.P., LarssonS.Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA 50 antigen in the diagnosis of lung cancer.Eur J Cancer1993; 29A: 198–202.
21.
BodyJ.J., PaesmansM., SculierJ.P.Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.Clin Chem1992; 38: 748–51.
22.
LippoK.K., TerhoT.Concomitant monitoring of serum neuron-specific enolase and creatine kinase BB in small cell lung cancer.Acta Oncol1991; 30: 321–4.
23.
JacquesG., BelperG., HolleK., WolfM., HannickT., GroppC., HavemannK.Prognostic value of pretreatment CEA, neuron specific enolase and creatine kinase BB in serum of patients with small cell lung cancer.Cancer1988; 62: 125–34.
24.
ZandwijkN., van JassemE., BonferJ.M., MooijW.J., van TinterenH.Serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy and survival in non-small cell lung cancer.Semin Oncol1992; 19(Suppl 2): 37–43.
25.
ShimokataK., NiwaY., YamamotoM., SasouH., MorishitaM.Pleural fluid neuron specific enolase: a useful diagnostic marker for small cell lung pleurisy.Chest1989; 95: 602–3.
26.
ScagliottiG.V., GattiE., MichelotoF.Neuron specific enolase levels in exudative pleural effusions.J Tumor Marker Oncol1990; 5: 373–7.
VillardJ.L., TigetF., HartmannO.Serum-neuron-specific/nonneuronal enolase ratio in diagnosis of neuroblastomas.Cancer1988; 62: 2546–53.
29.
CaillardJ.M., Martinez-MadrigalF., HartmannO., CarluC.Immunohistochemical demonstration of neurone specific enolase in bone marrow infiltrated by neuroblastoma. J.Clin Pathol1991; 44: 309–12.
30.
MuchiH., IjimaH., ShimoizumiH.Detection of neuroblastoma cells in the bone marrow with immunohistochemical staining of neuron-specific enolase (letter).Pediatr Hematol Oncol1989; 6: 63–6.
31.
TakashiM., HaimotoH., TanakaJ., MuraseT., KatoK.L.Evaluation of gamma-enolase, a tumour marker for renal cell carcinoma.J Urol1989; 141: 830–44.
32.
PlowmanP.N.Serum marker for Merkel cell tumour (letter).Clin Radiol1989; 40: 542.
33.
CunninghamR.T., JohnstonC.F., IrvineG.B., BuchananK.D.Serum neuron-specific enolase levels in patients with neuroendocrine and carcinoid tumours.Clin Chim Acta1992; 212: 123–31.
34.
KawataM., SekiyaS., HatakeyamaH., TakamizawaH.Neuron specific enolase, a serum marker for immature teratoma and dysgerminoma.Gynecol Oncol1989; 32: 191–7.
35.
GrouzmannE., GicquelC., PlouinP.F., SchlumbergerM., ComoyE., BohuonC.Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheo-chromocytomas.Cancer1990; 66: 1835.
36.
O'ConnorT.P., WadeT.P., SunwooY.C.Small cell undifferentiated carcinoma of the pancreas: report of a patient with marker studies.Cancer1992; 70: 1514–9.
37.
LorenzJ., DippoldW.Neuron-specific enolase: a marker for malignant melanoma.J Natl Cancer Inst1989; 81: 1754–5.
38.
WibeE., HannisdaleE., PausE., AamdalS.Neuron specific enolase as a prognostic factor in metastatic malignant melanoma.Eur J Cancer1992; 28A: 1692–5.
39.
ShineB.S.F., HungerfodJ., VaghelaB., SheraidahG.A.K.Electrophoretic assessment of aqueous and serum neurone specific enolase in retinoblastoma and ocular malignant melanoma.Br J Ophthalmol1990; 74: 427–30.
40.
FossåS.D., KleppO., PausE.Neuron-specific enolase: a serum marker in seminoma?Br J Cancer1992; 65: 297–9.
41.
KarkelaJ., BockE., KaukinenS.CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man.J Neuro Sci1993; 116: 100–9.
42.
RioneR.O., SomerH., KasteM., ViinkkaL., KaronenS-L.Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis.Arch Neurol1989; 46: 753–6.
43.
SellmanM., IvertT., RonquistG., PerssonL., SembB.K.H.Central nervous system damage during cardiac surgery assessed by 3 different biochemical markers in cerebrospinal fluid.Scand J Thor Cardio Surg1992; 26: 39–45.
44.
MokunoK., YasudaT., SugimuraK., RikuS., TakahashiA., KatoK.Cerebrospinal fluid neuron-specific enolase (NSE) and S-100b protein in Guillain-Barre syndrome - their relations to prognosis.Rinsho Shinkeigaku1992; 32: 535–7.
45.
VermuytenK.Determination of glial fibrillary acidic protein, S100, myelin basic protein and neuron specific enolase in cerebrospinal fluid from patients suffering from dementia.Acta Neurol Belg1989; 89: 318.
46.
EganM.F., el-MallakhR.S., SuddathR.L., LohrJ.B., BrachaH.S., WyattR.J.Cerebrospinal fluid and serum levels of neuron-specific enolase in patients with schizophrenia.Psychiat Res1992; 43: 87–95.
47.
BeelenM.A., TwijnstraA., van der PolM., MenheerePPCA.Neuron-specific enolase in cerebrospinal fluid of patients with metastatic and non-metastatic neurological disease.Eur J Cancer1993; 29A: 193.
48.
BioardiA., MunariL., SilvaniA., SoleroC.L., BombardieriE.Neuron specific enolase (NSE) and thymidine kinase (TK) as markers in biological fluids of brain tumor patients.It J Neurol Sci1990; 11: 359–66.
